Proacta Company

Proacta is a clinical-stage biopharmaceutical company developing hypoxia-activated ’prodrugs“ for the treatment of cancer.

Industry: PharmTech
Technology: Others
Funding Status: Early Stage Venture
Investment Stage: N/A
Investors Number: 7
Headquarters: La Jolla, California, United States
Employee Number: 1-10
Number Of Exists: N/A
Investor Type: N/A
Total Funding: $47M
Founded Date: 2004
Last Funding Type: Debt Financing